South China Morning Post · Jefferies
Hong Kong attracts wave of biotech IPO filings amid AI drug boom
· By Julie Zhang
Story summaryMore than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest
Read at South China Morning Post ↗
Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.